REDWOOD-HCM, SEQUOIA-HCM and FOREST-HCM trials: Incidence and impact of atrial fibrillation in oHCM with aficamten
29 August 2025 (07:00 - 18:00)
Organised by: 
About the speaker
Oregon Health & Science University Medical Group, Portland (United States of America)
3 More presentations in this session
Professor C. Miller (Manchester, GB)
Access the full session
The Event
ESC Congress 2025
29 August - 1 September 2025
You may be interested in
Congress Presentation
